Skip to content. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. Grants & Donations - U.S. Abbott has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and healthcare issues that improve patient care. 2016 A N N U A L R E P O R T Abbott is a globally diversified healthcare company whose central purpose is to help people, at all the 2015 Other (income) expense, net includes a gain on the sale of a portion of Abbott's position in Mylan stock and a decrease in the fair value of contingent consideration related to a business acquisition, both reported as specified items. Add Files. This textbook can be purchased at www.amazon.com, Consolidated Financial Statements and Notes, Financial Instruments and Risk Management, CONTINUAL, FOCUSED EVOLUTION. TABLE OF CONTENTS 1 Letter to Shareholders 5 Building Abbott 16 Medical Devices 20 Diagnostics 24 Established Pharmaceuticals . Worldwide Adult Nutrition sales decreased 1.4 percent on a reported basis in the fourth quarter, including an unfavorable 1.0 percent effect of foreign exchange, and decreased 0.4 percent on an operational basis. Condensed Consolidated Statement of Earnings, Fourth Quarter Ended December 31, 2016 and 2015, Cost of products sold, excluding amortization expense, Earnings from Continuing Operations before taxes, Taxes on Earnings from Continuing Operations, Earnings from Discontinued Operations, net of taxes, Net Earnings from Continuing Operations, excluding, Diluted Earnings per Common Share from Continuing, Operations, excluding Specified Items, as described below, Average Number of Common Shares Outstanding. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. Specified items reflect intangible amortization expense of $121 million and other expenses of $196 million, primarily associated with acquisitions, including bridge facility fees and other debt related costs, charges related to cost reduction initiatives and other expenses. The website you have requested also may not be optimized for your specific screen size. In the quarter, worldwide growth of Ensure was offset primarily by a difficult comparison to fourth quarter 2015, which included new product distributions in the U.S. and China. Copies of Abbott's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) . out of 161. "2016 was a very important year for Abbott," said Miles D. White, chairman and chief executive officer, Abbott. Your generous gifts will change our students for the better. Dilution of a company's common shareholders usually refers to: (one answer) A. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. In the interest of transparency, we are disclosing the following list of professional conferences sponsored by Abbott. These instruments belong to Abbott's new Alinity family of harmonized systems, which were designed to be more efficient running more tests in less space, generating test results faster and minimizing human errors while continuing to provide quality results. 2016 A N N UA L R E P O R T . 2016 Other (income) expense, net includes a charge of $947 million related to an adjustment of Abbott's holdings of Mylan N.V. ordinary shares to reflect the share price as of Sept. 30, 2016. Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Announcements. The website you have requested also may not be optimized for your specific screen size. 2016 Tax expense on Earnings from Continuing Operations includes the impact of a net tax benefit of approximately $225 million, primarily as a result of the resolution of various tax positions from prior years, partially offset by the unfavorable impact of non-deductible foreign exchange losses related to Venezuela and an adjustment to the equity investment in Mylan and the recognition of deferred taxes associated with the pending sale of AMO. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. This preview shows page 1 - 5 out of 80 pages. Specified items include acquisition-related expenses, intangible amortization expense, charges associated with cost reduction initiatives and other expenses, partially offset by a gain on the sale of the Abbott Medical Optics business (AMO). 2017 Mar;69(3 Suppl 1):A7-A8. Abbott continues to evaluate other ways to enhance transparency. Abbott's cash dividend is payable Feb. 15, 2017, to shareholders of record at the close of business on Jan. 13, 2017. Financial Data. 7 download. Point of Care Diagnostics sales increased 8.1 percent on a reported basis in the fourth quarter, including a favorable 0.1 percent effect of foreign exchange, and increased 8.0 percent on an operational basis. We Highlighted This SEC Filing For You. INVESTORS. Twitter. Abbott Laboratories' has a defined benefit retirement plan. a)Includes DES / BVS product portfolio, structural heart, guidewires, balloon catheters and other coronary products. Financial Reports for Healthcare-Related Organizations. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. E-Mail. We partner with a broad range of organizations to help address today's healthcare challenges. By delivering results in ten minutes or less using only two to three drops of blood, i-STATAlinityprovides healthcare professionals the information needed to make fast and accurate medical decisions without ever leaving their patient's side. Financial Reports for Healthcare-Related Organizations. Annual Reports. Reported diluted EPS from . Second Edition 2016. View Abbott 2016 AR_3.27.17.pdf from ACCOUNTING ECON42123 at Durham University. First Edition 2016. LinkedIn. https://www.ethicalmedtech.eu/transparent-medtech/, Sponsored Professional Conferences (January 2022 to June 2022), Sponsored Professional Conferences (January 1 to December 31, 2021), FINANCIAL REPORTS FOR HEALTHCARE RELATED ORGANIZATIONS. ABBOTT PARK, Ill., Jan. 25, 2017 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2016. 1 2 . Quick Links. ABBOTT PAKISTAN2016 ANNUAL REPORT 3 Values are the foundation for building a meaningful corporate identity. The website that you have requested also may not be optimized for your screen size. Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. ABBOTT DECLARES 369 TH QUARTERLY DIVIDEND. 2016 Earnings, net of taxes and Diluted Earnings per Common Share from Discontinued Operations primarily reflect the impact of a net tax benefit of $325 million as a result of the resolution of various tax positions from prior years. Key Emerging Markets include Brazil, Russia, India and China (BRIC), along with several additional emerging markets that represent the most attractive long-term growth opportunities for Abbott's branded generics product portfolio. Abbott forecasts net specified items for the full year 2017 of approximately $1.48 per share. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Any country-specific considerations are identified in the Methodological Note. Abbott is a globally diversi ed healthcare company whose central purpose is to help people, at all stages of life, live their NUTRITION Abbott Understands That Proper Nutrition Is The Foundation For Full And Healthy Lives. Worldwide sales of Vascular products increased 2.9 percent on a reported basis in the fourth quarter, including an unfavorable 0.3 percent effect of foreign exchange, and increased 3.2 percent on an operational basis. Category: Documents. Abbott is proud to be a Corporate Member of MedTech Europe. . Sales growth in Vascular products was led by double-digit growth of MitraClip, Abbott's device for the treatment of mitral regurgitation, as Abbott continues to build the market for this first-in-class device. 2015 Net Earnings from Continuing Operations, excluding Specified Items, excludes net after-tax charges of $237 million, or $0.16 per share, for intangible amortization expense, expenses associated with cost reduction initiatives and other expenses related to acquisitions. Director & CEO Profile. As expected, the planned scale down of the genetics business offset growth in the infectious disease testing business. Sales in these key geographies increased 10.6 percent on a reported basis and 13.0 percent on an operational basis in the fourth quarter. The website that you have requested also may not be optimized for your screen size. Second Edition 2014. ; Reported diluted EPS from continuing operations under GAAP was $0.40 in the second quarter. diversified healthcare company whose central 1 Letter to Shareholders 5 Building Abbott purpose is to help people, 16 Medical Devices at all stages of life, live their 20 Diagnostics best possible lives through 24 Established Pharmaceuticals better health. Abbott Laboratories Designer David Wozniak, Tim Hartford, Brandon Murray Category Print Pharmaceuticals Country . Since 1948, Abbott has been dedicated to helping people in Pakistan live healthier lives through a diverse range of science-based nutritional products, diagnostic tools, pharmaceuticals and diabetes devices. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. During the quarter, Abbott obtained CE Mark for its i-STAT Alinity handheld portable blood testing system. University of Texas, Dallas ACCOUNTING 6344, University of California, Los Angeles MGMT 120A, Johnson and Johnson Annual Report 2016 (1).pdf, London School of Business and Finance ACCOUNTING 10, Four common elements to occupational fraud and abuse schemes were first, Reanswer the previous question 29 Pete had been in adverse possession of, Tunku Abdul Rahman University College, Kuala Lumpur, Institute of Business Administration, Karachi (Main Campus), Are the criteria for research given equal weight A Yes B No organization is, Answer False Page 60 Level of difficulty Easy 94 When a manager reaches the, A recession can best be defined as a period of time in which a total output of, 6 Which type of innovation relies on a significant change in thinking a Product, 16 On this period the English came to be used as a medium of instruction in the, In the Shadow of No Tower 911 of Art Spiegelmen is aan A epic B flash fiction C, 4 is most commonly found in the terminal ileum and beginning of the colon o, 205 Participative leadership means involving employees in making work related, 267 Chaplets are used in the mold for DRDO2008 a enhancing the rate of, Horngren's Financial & Managerial Accounting, Horngren's Financial & Managerial Accounting, The Financial Chapters, Horngren's Financial & Managerial Accounting, The Managerial Chapters, Horngren's Accounting: The Managerial Chapters, Horngren's Cost Accounting: A Managerial Emphasis, Horngren's Accounting, The Financial Chapters, Jay Company has net income of $10,000 in 2010. 2016 Net foreign exchange (gain) loss includes a loss of $480 million related to the revaluation of Abbott's net monetary assets in Venezuela using the Dicom exchange rate, which is the Venezuelan government's official floating exchange rate. Annual Report 2016 ABOT - Abbott Laboratories (Pakistan) Limited. Worldwide Nutrition sales decreased 3.7 percent on a reported basis in the fourth quarter, including an unfavorable 1.1 percent effect of foreign exchange, and decreased 2.6 percent on an operational basis. Abbott Reports First-Quarter 2016 Results . Worldwide Medical Optics sales increased 7.7 percent on a reported basis in the fourth quarter, including a favorable 0.8 percent effect of foreign exchange, and increased 6.9 percent on an operational basis. Full-year worldwide sales increased 2.2 percent on a reported basis and 4.8 percent on an operational basis. . Molecular Diagnostics sales decreased 7.6 percent on a reported basis in the fourth quarter, including an unfavorable 0.7 percent effect of foreign exchange, and decreased 6.9 percent on an operational basis. Their beginning common shares outstanding is 20,000. The College oers eleven pre-univer-sity and eleven career programs to over 6500 full-time students per semester, as well as a wide range of Continuing Education . Abbott Laboratories revenue for the twelve months ending September 30, 2022 was $45.030B, a 6.43% increase year-over-year. Post on 20-Apr-2018. 2019 Annual Report 8.3 MB. Abbott has a long-standing commitment to supporting programs aimed at increasing the understanding of scientific, clinical and healthcare issues that improve patient care. Authors Rajiv Saran, Bruce Robinson, Kevin C Abbott, Lawrence Y C Agodoa, Patrick Albertus, John Ayanian, Rajesh Balkrishnan, Jennifer . Recipients include medical and other healthcare professional organizations, patient organizations, academic institutions, hospitals, medical education companies and other scientific associations. First Edition 2015. This is the declaration date for latest dividend payment reported by the company. Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. ABBOTT ISSUES EARNINGS-PER-SHARE OUTLOOK FOR 2017. Abbott forecasts specified items for the first quarter 2017 of $0.23 related to the same items discussed above for the full year 2017. Jan 25, 2017, 06:45 ET. Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news. A reconciliation of the full-year tax rates for continuing operations for 2016 and 2015 is shown below: Full-year 2015 tax rate includes the impact of U.S. tax legislation passed in Dec. 2015, including the R&D tax credit. All Rights Reserved. Initial Public Offerings (IPO) Free Datasets. The ending share, Olga Sorescu Company uses the average cost method to account for lawn chair inventory and has the following activity during the month of March, 2009. ANNUAL REPORT 2016 ANNUAL REPORT. See tables below for an explanation of certain non-GAAP financial information. Following are sales by business segment and commentary for the fourth quarter and the full year: * Total Abbott Sales from continuing operations include Other Sales of $11 million. 2016 ANNUAL REPORT TABLE OF CONTENTS 1 Letter to Shareholders 5 Building Abbott 16 Medical Devices 20 Diagnostics 24 Established Pharmaceuticals 28 Nutrition 32 Financial Report 33 Consolidated Financial Statements and Notes 57 Management Report on Internal Control Over Financial Reporting 58 Report of Independent Registered Annual Report 2016 (PDF document | 6.02MB) Annual Report 2015 (PDF document | 4.98MB) 9/2002 General Information and Questionnaire Basis for Allocation of Costs Name of Facility License No. Abbott is a company rooted in values and our core values of honesty, integrity and fairness describe a standard of behavior expected of every Abbott employee. Previous Next. 2021 Global Sustainability Report Summary. A Caution Concerning Forward-Looking Statements. At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve.